All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, August 15, 2022
Home » Blogs » BioWorld Perspectives » Venter, Watson Warm Up for Clash of the Titans

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld / European Medicines Agency

Venter, Watson Warm Up for Clash of the Titans

July 10, 2012
By Cormac Sheridan
No Comments

DUBLIN ‑ Europe's biggest scientific carnival is pitching its tent beside the River Liffey this week. Dublin is playing host to the Euroscience Open Forum (ESOF) 2012 meeting and, thereby, assumes the mantle of Europe's City of Science for the year.

Conceived as Europe's answer to the annual meeting of the American Association for the Advancement of Science, ESOF has become an increasingly visible element in Europe's efforts to foster a shared scientific identity. Although different European countries have vastly differing scientific heritages, their scientific futures are converging, thanks to an increasing level of recognition, both in Brussels and across the continent, that the region can only compete on a global basis if it acts in concert.

Ireland's bid to host the event was originally conceived as its coming of age as a location for high quality scientific research, following an expansive strategy that began just over a decade ago. At present, however, the mood is not entirely celebratory. The present government's commitment to open-ended, blue-skies research has wavered, following a catastrophic banking collapse in 2008, which culminated in the country entering a bailout program administered by the International Monetary Fund and the European Central Bank. Although funding for science has held up, just about, a recent sharp turn to a more industrially focused research agenda has been met with anger and dismay by some of the country's leading scientists.

Even so, there will be plenty to celebrate in Dublin this week ‑ in terms of both homegrown successes and the very best of international science. The recent (apparent) detection of the Higgs boson at CERN, in Geneva, will provide one important focus for the meeting. CERN's director general Rolf Heuer will be in town. But the physicists will have to share the limelight with a clutch of heavyweights from the life sciences world, including Nobel laureates Jules Hoffman (2011), Peter Doherty (1996), Torsten Niels Wiesel (1981) and James Watson (1962).

One event of interest to both camps will be Craig Venter's What is Life lecture at Trinity College Dublin on Thursday evening. This will commemorate the original 1943 lecture series by Erwin Schroedinger, one of the founders of quantum mechanics, who spent 14 years in Dublin during and after the Second World War. Schroedinger's book of the same name, which appeared in 1944, was a key text in the early development of molecular biology and a source of inspiration for James Watson and Francis Crick. Watson will be on hand to respond to Venter's address. It might be an exaggeration to dub the event Clash of the Titans, but it's an intriguing prospect nonetheless.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Aug. 15, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Aug. 15, 2022.
  • Amvuttra

    Alnylam’s Amvuttra rare disease drug among positive recommendations from Europe’s CHMP

    BioWorld
    Alnylam Pharmaceuticals Inc.’s Amvuttra (vutrisiran), a treatment for the rare disease hereditary transthyretin-mediated amyloidosis, was among medicines...
  • Pig organ cells

    Whole body cellular function recovery in pigs after death

    Science
    A new system for restoring cell function and tissues in mammals after death could expand the availability of organs for transplantation. The research also opens...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing